Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 juil. 2026 08h19 HE | Source: Faruqi & Faruqi LLP

ADMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ADMA Biologics To Contact Him Directly To Discuss Their Options If you purchased...
10 juil. 2026 14h48 HE | Source: The Rosen Law Firm PA

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024...
09 juil. 2026 09h19 HE | Source: Bernstein Liebhard LLP

ADMA BIOLOGICS, INC. (ADMA) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ADMA Biologics, Inc. Investors of Upcoming Deadline

ADMA Biologics Shareholders Between August 9, 2024 and March 25, 2026 - Contact Bernstein Liebhard For More Information Regarding Lawsuit
08 juil. 2026 12h07 HE | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for VIA, Z, ADMA, and ERAS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 08, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
07 juil. 2026 16h50 HE | Source: Robbins Geller Rudman & Dowd LLP

ADMA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

The case alleges ADMA Biologics and certain of its executives made false and/or misleading statements to investors.
07 juil. 2026 15h22 HE | Source: The Rosen Law Firm PA

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024...
07 juil. 2026 13h21 HE | Source: Bragar Eagel & Squire

ADMA BIOLOGICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. and Encourages Investors to Contact the Firm

If you purchased or acquired ADMA Biologics securities between August 9, 2024 and March 25, 2026 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or...
07 juil. 2026 09h37 HE | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)

ADMA Biologics Shareholders Between August 9, 2024 and March 25, 2026 - Contact Bernstein Liebhard For More Information Regarding Lawsuit
07 juil. 2026 08h18 HE | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and New Era Energy & Digital, Inc. (NASDAQ: NUAI) (FKA New Era Helium (NASDAQ: NEHC)): Grabar Law Office is Investigating Claims on Your Behalf

ADMA Biologics, Inc. (NASDAQ: ADMA); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and New Era Energy & Digital, Inc. (NASDAQ: NUAI)
05 juil. 2026 11h50 HE | Source: Faruqi & Faruqi LLP

ADMA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ADMA Biologics To Contact Him Directly To Discuss Their Options If you purchased...

Page suivante